Abstract
We have shown previously that transforming growth factor-beta (TGF-beta) is a potent tumour suppressor in Smad4-deficient human malignant oral keratinocytes but the mechanism by which this occurs is unknown. In the present study, we show that over-expression of TGF-beta1 causes regression of tumours derived from Smad4-deficient oral keratinocytes transplanted orthotopically to athymic mice. Further, tumour regression is associated with the induction of apoptosis without changes in cell proliferation. In vitro, TGF-beta1 did not induce apoptosis directly in these cells but sensitized cells to cisplatin, but not Fas, -induced cell death. The data suggest that TGF-beta1 induces tumour regression in vivo by Smad4-independent pathways that sensitize keratinocytes to mitochondrial-mediated apoptosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis* / drug effects
-
Cisplatin / pharmacology
-
DNA-Binding Proteins / deficiency
-
DNA-Binding Proteins / physiology*
-
Drug Synergism
-
Humans
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Mouth Neoplasms / metabolism
-
Mouth Neoplasms / pathology*
-
Neoplasm Proteins / deficiency
-
Neoplasm Proteins / physiology
-
Neoplasm Regression, Spontaneous / pathology*
-
Neoplasm Regression, Spontaneous / physiopathology
-
Neoplasm Transplantation
-
Recombinant Proteins / pharmacology
-
Smad4 Protein
-
Trans-Activators / deficiency
-
Trans-Activators / physiology*
-
Transforming Growth Factor beta / metabolism
-
Transforming Growth Factor beta / pharmacology
-
Transforming Growth Factor beta / physiology*
-
Transforming Growth Factor beta1
-
Transplantation, Heterologous
-
Tumor Cells, Cultured
Substances
-
DNA-Binding Proteins
-
Neoplasm Proteins
-
Recombinant Proteins
-
SMAD4 protein, human
-
Smad4 Protein
-
TGFB1 protein, human
-
Tgfb1 protein, mouse
-
Trans-Activators
-
Transforming Growth Factor beta
-
Transforming Growth Factor beta1
-
Cisplatin